News December 16, 2019 GNS561 to treat pancreas or colorectal cancer with liver metastasis GENOSCIENCE PHARMA Announces Extension of GNS561 Phase 1/2 Clinical Trial to Patients with Pancreas or…Read More
News November 14, 2019 Outstanding Data on GNS561 in Combination with a PD-1 Inhibitor Outstanding Data on GNS561 in Combination with a PD-1 Inhibitor to Be Presented at the…Read More
News September 25, 2019 Invest in the Future of Health Biotech, European Biotech Week Invest in the Future of Health Biotech during the European Biotech Week 2019 (Brussels) …Read More
News June 3, 2019 S.A.B Meeting in Chicago, during ASCO 2019 Scientific Advisory Board Meeting during ASCO 2019 Chicago, USA, June 3, 2019 — Genoscience…Read More
News April 17, 2019 Chaim Hurvitz, New Board of Directors Member Chaim Hurvitz, New Board of Directors Member Chaim Hurvitz has joined Genoscience Pharma Board…Read More
News December 10, 2018 Most Innovative European Biotech SME for 2018 Most Innovative European Biotech SME for 2018 Bruxelles, Belgium, December 3, 2018 - Company…Read More
News October 5, 2018 Extension to US of GNS561 Clinical Trial Genoscience Pharma Extends to US its Clinical Trial in Patients with Advanced Liver Cancers …Read More
News June 4, 2018 S.A.B. Meeting in Chicago, during ASCO 2018 Scientific Advisory Board Meeting during ASCO 2018 Chicago, USA, June 4, 2018 — During…Read More
News May 22, 2018 Extension to France of GN561 Clinical trial Genoscience Pharma Extends its GNS561 Clinical Trial to France Enrollment is open for patients…Read More
News April 5, 2018 First-in-human Dosing of GNS561 in Liver Cancer Patients First-in-human Dosing of GNS561 in Patients with Advanced Liver Cancer at the Jules Bordet Institute,…Read More